HCPCS J9329 — Inj, tislelizumab-jsgr (2026 RVU Values)
HCPCS code J9329 (Inj, tislelizumab-jsgr) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
HCPCS code J9329 (Inj, tislelizumab-jsgr) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.